Tumour fatty acid metabolism in the context of therapy resistance and obesity

AJ Hoy, SR Nagarajan, LM Butler - Nature Reviews Cancer, 2021 - nature.com
Fatty acid metabolism is known to support tumorigenesis and disease progression as well
as treatment resistance through enhanced lipid synthesis, storage and catabolism. More …

[HTML][HTML] Lipid metabolism and cancer

X Bian, R Liu, Y Meng, D Xing, D Xu, Z Lu - Journal of Experimental …, 2021 - rupress.org
Dysregulation in lipid metabolism is among the most prominent metabolic alterations in
cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological …

Emerging functions of the EGFR in cancer

S Sigismund, D Avanzato, L Lanzetti - Molecular oncology, 2018 - Wiley Online Library
The physiological function of the epidermal growth factor receptor (EGFR) is to regulate
epithelial tissue development and homeostasis. In pathological settings, mostly in lung and …

Lipids in the tumor microenvironment: From cancer progression to treatment

KC Corn, MKA Windham, M Rafat - Progress in lipid research, 2020 - Elsevier
Over the past decade, the study of metabolic abnormalities in cancer cells has risen
dramatically. Cancer cells can thrive in challenging environments, be it the hypoxic and …

Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer

Z Tracz-Gaszewska, P Dobrzyn - Cancers, 2019 - mdpi.com
A distinctive feature of cancer cells of various origins involves alterations of the composition
of lipids, with significant enrichment in monounsaturated fatty acids. These molecules, in …

[HTML][HTML] Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer

C Wang, M Shi, J Ji, Q Cai, Q Zhao, J Jiang… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Cancer cells are characterized by metabolic alterations. Thereinto, Stearoyl-CoA
Desaturase 1 (SCD1), an enzymatic node located in the conversion of saturated fatty acids …

Novel insights on lipid metabolism alterations in drug resistance in cancer

R Yang, M Yi, B Xiang - Frontiers in cell and developmental biology, 2022 - frontiersin.org
Chemotherapy is one of the primary treatments for most human cancers. Despite great
progress in cancer therapeutics, chemotherapy continues to be important for improving the …

EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells

S Talukdar, L Emdad, SK Das, PB Fisher - Advances in cancer research, 2020 - Elsevier
Abstract The Epidermal Growth Factor Receptor (EGFR) is frequently expressed at elevated
levels in different forms of cancer and expression often correlates positively with cancer …

Reprogramming of lipid metabolism in lung cancer: An overview with focus on EGFR-Mutated non-small cell lung cancer

K Eltayeb, S La Monica, M Tiseo, R Alfieri, C Fumarola - Cells, 2022 - mdpi.com
Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are
classified as non-small cell lung cancers (NSCLC). EGFR has become an important …

Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches

C Navarro, Á Ortega, R Santeliz, B Garrido, M Chacín… - Pharmaceutics, 2022 - mdpi.com
The constant changes in cancer cell bioenergetics are widely known as metabolic
reprogramming. Reprogramming is a process mediated by multiple factors, including …